First-trimester prediction of preeclampsia in nulliparous women at low risk

Obstetrics and Gynecology

Volumn 119, Issue 6, 2012, Pages 1234-1242

  Myatt, Leslie ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q}   Clifton, Rebecca G ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q}   Roberts, James M ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q}   Spong, Catherine Y ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q}   Hauth, John C ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q}   Varner, Michael W ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q}   Thorp, John M ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q}   Mercer, Brian M ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q}   Peaceman, Alan M ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q}   Ramin, Susan M ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q}   Carpenter, Marshall W ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q}   Iams, Jay D ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q}   Sciscione, Anthony ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q}   Harper, Margaret ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q}   Tolosa, Jorge E ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q}   Saade, George ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q}   Sorokin, Yoram ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q}   Anderson, Garland D ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q}  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF UTAH   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f METROHEALTH MEDICAL CENTER   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

^h UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

ⁱ BROWN UNIVERSITY   (United States)

^j OHIO STATE UNIVERSITY   (United States)

^k DREXEL UNIVERSITY   (United States)

^l WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^m OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁿ UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^o WAYNE STATE UNIVERSITY   (United States)

^p GEORGE WASHINGTON UNIVERSITY   (United States)

^q EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADAM 12 PROTEIN; ADAM PROTEIN; ENDOGLIN; PLACENTA PROTEIN; PLACENTAL GROWTH FACTOR; PLACENTAL PROTEIN 13; PREGNANCY ASSOCIATED PLASMA PROTEIN A; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1;

ADULT; ANGIOGENESIS; ARTICLE; BLOOD CELL COUNT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CAREGIVER; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MARRIAGE; MATERNAL AGE; MULTICENTER STUDY; NULLIPARA; OBSERVATIONAL STUDY; PREDICTION; PREECLAMPSIA; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SOCIAL STATUS; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE VOLUME; TROPHOBLAST;

ADAM PROTEINS; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANTIGENS, CD; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GALECTINS; HUMANS; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; PARITY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; RECEPTORS, CELL SURFACE; RISK; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; YOUNG ADULT;

EID: 84861624269     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3182571669     Document Type: Article

References (36)

1. World Health Organization. Estimates of maternal mortality: a new approach by WHO and UNICED. Geneva (Switzerland): World Health Organization; 1996.
2. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995;345: 1455-63.
3. Myatt L, Carpenter L. Prediction of preeclampsia. In: Lyall F, Belfort M, editors. Preeclampsia etiology and clinical practice. Cambridge (UK): Cambridge University Press; 2007.
4. Irwin JC, Suen LF, Cheng BH, Martin R, Cannon P, Deal CL, et al. Human placental trophoblasts secrete a disintegrin metalloproteinase very similar to the insulin-like growth factor binding protein-3 protease in human pregnancy serum. Endocrinology 2000;141:666-74.
5. Tornehave D, Chemnitz J, Teisner B, Folkersen J, Westergaard JG. Immunohistochemical demonstration of pregnancy-associated plasma protein A (PAPP-A) in the syncytiotrophoblast of the normal placenta at different gestational ages. Placenta 1984;5:427-31.
6. Irwin JC, Suen LF, Martina NA, Mark SP, Giudice LC. Role of the IGF system in trophoblast invasion and pre-eclampsia. Hum Reprod 1999;14(Suppl 2):90-6.
7. Bohn H, Kraus W, Winckler W. Purification and characterization of two new soluble placental tissue proteins (PP13 and PP17). Oncodev Biol Med 1983;4:343-50.
8. Howarth S, Marshall LR, Barr AL, Evans S, Pontre M, Ryan N. Platelet indices during normal pregnancy and pre-eclampsia. Br J Biomed Sci 1999;56:20-2.
9. Norris LA, Sheppard BL, Burke G, Bonnar J. Platelet activation in normotensive and hypertensive pregnancies complicated by intrauterine growth retardation. Br J Obstet Gynaecol 1994;101:209-14.
10. Roberts JM, Myatt L, Spong CY, Thom EA, Hauth JC, Leveno KJ, et al. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med 2010;362: 1282-91.
11. Thadhani R, Ecker JL, Kettyle E, Sandler L, Frigoletto FD. Pulse pressure and risk of preeclampsia: a prospective study. Obstet Gynecol 2001;97:515-20.
12. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-36.
13. North RA, McCowan LM, Dekker GA, Poston L, Chan EH, Stewart AW, et al. Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort. BMJ 2011;342:d1875.
14. Nijdam ME, Janssen KJ, Moons KG, Grobbee DE, van der Post JA, Bots ML, et al. Prediction model for hypertension in pregnancy in nulliparous women using information obtained at the first antenatal visit. J Hypertens 2010;28:119-26.
15. Dekker GA, Robillard PY, Hulsey TC. Immune maladaptation in the etiology of preeclampsia: a review of corroborative epidemiologic studies. Obstet Gynecol Surv 1998;53:377-82.
16. Kho EM, McCowan LM, North RA, Roberts CT, Chan E, Black MA, et al. Duration of sexual relationship and its effect on preeclampsia and small for gestational age perinatal outcome. J Reprod Immunol 2009;82:66-73.
17. Chesley LC, Annitto JE, Cosgrove RA. The familial factor in toxemia of pregnancy. Obstet Gynecol 1968;32:303-11.
18. Cincotta RB, Brennecke SP. Family history of pre-eclampsia as a predictor for pre-eclampsia in primigravidas. Int J Gynaecol Obstet 1998;60:23-7.
19. Tygart SG, McRoyan DK, Spinnato JA, McRoyan CJ, Kitay DZ. Longitudinal study of platelet indices during normal pregnancy. Am J Obstet Gynecol 1986;154:883-7.
20. Varol E, Akcay S, Icli A, Yucel H, Ozkan E, Erdogan D, et al. Mean platelet volume in patients with prehypertension and hypertension. Clin Hemorheol Microcirc 2010;45:67-72.
21. Varol E, Akcay S, Ozaydin M, Erdogan D, Dogan A, Altinbas A. Mean platelet volume is associated with insulin resistance in non-obese, non-diabetic patients with coronary artery disease. J Cardiol 2010;56:154-8.
22. von Dadelszen P, Magee LA, Devarakonda RM, Hamilton T, Ainsworth LM, Yin R, et al. The prediction of adverse maternal outcomes in preeclampsia. J Obstet Gynaecol Can 2004;26:871-9.
23. Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta 2009;30(Suppl A):S32-7.
24. Gack S, Marme A, Marme F, Wrobel G, Vonderstrass B, Bastert G, et al. Preeclampsia: increased expression of soluble ADAM 12. J Mol Med 2005;83:887-96.
25. Laigaard J, Sorensen T, Placing S, Holck P, Frohlich C, Wojdemann KR, et al. Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia. Obstet Gynecol 2005;106:144-9.
26. Spencer K, Cowans NJ, Stamatopoulou A. ADAM12s in maternal serum as a potential marker of pre-eclampsia. Prenat Diagn 2008;28:212-6.
27. Poon LC, Stratieva V, Piras S, Piri S, Nicolaides KH. Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11-13 weeks. Prenat Diagn 2010;30:216-23.
28. Spencer K, Cowans NJ, Nicolaides KH. Low levels of maternal serum PAPP-A in the first trimester and the risk of preeclampsia. Prenat Diagn 2008;28:7-10.
29. Gonen R, Shahar R, Grimpel YI, Chefetz I, Sammar M, Meiri H, et al. Placental protein 13 as an early marker for preeclampsia: a prospective longitudinal study. BJOG 2008;115: 1465-72.
30. Chafetz I, Kuhnreich I, Sammar M, Tal Y, Gibor Y, Meiri H, et al. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 2007;197:35e1-7.
31. Huppertz B, Sammar M, Chefetz I, Neumaier-Wagner P, Bartz C, Meiri H. Longitudinal determination of serum placental protein 13 during development of preeclampsia. Fetal Diagn Ther 2008;24:230-6.
32. Stamatopoulou A, Cowans NJ, Matwejew E, von Kaisenberg C, Spencer K. Placental protein-13 and pregnancy-associated plasma protein-A as first trimester screening markers for hypertensive disorders and small for gestational age outcomes. Hypertens Pregnancy 2011;30:384-95.
33. Spencer K, Cowans NJ, Chefetz I, Tal J, Meiri H. Firsttrimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of preeclampsia. Ultrasound Obstet Gynecol 2007;29:128-34.
34. Akolekar R, Syngelaki A, Beta J, Kocylowski R, Nicolaides KH. Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia. Prenat Diagn 2009;29:1103-8.
35. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006;355:992-1005.
36. Myatt L, Miodovnik M. Prediction of preeclampsia. Semin Perinatol 1999;23:45-57.